Topical Dorzolamide for Idiopathic Macular Hole

Not Applicable

Recruiting

• Conditions: Idiopathic macular hole; Eye - Diseases / disorders of the eye

• Registration Number: ACTRN12619000660189
• Lead Sponsor: South Australian Institute of Ophthalmology

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2019-05-02
• Last Update Posted: 7 September 2021

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 26

Inclusion Criteria

Ability to provide informed consent and complete study assessments
Age 18 years or older
Idiopathic macular hole in study eye

Exclusion Criteria

Renal impairment with creatinine clearance <30ml/min.
Other retinal pathology

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Closure of macular hole as assessed with optical coherence tomography[8 weeks post initiation of treatment.]

Secondary Outcome Measures

Name	Time	Method
Visual acuity measured in letters using an ETDRS chart[8 weeks post initiation of treatment.];Central retinal thickness as assessed with optical coherence tomography[8 weeks post initiation of treatment.]